Charles Schwab Investment Management Inc Century Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 152,051 shares of IPSC stock, worth $387,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
152,051
Previous 148,761
2.21%
Holding current value
$387,730
Previous $493,000
28.8%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IPSC
# of Institutions
67Shares Held
19.7MCall Options Held
10.6KPut Options Held
300-
Vr Adviser, LLC New York, NY3.41MShares$8.68 Million1.22% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$8.18 Million1.08% of portfolio
-
Boxer Capital, LLC San Diego, CA1.75MShares$4.46 Million0.38% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$3.82 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.31MShares$3.33 Million1.32% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $150M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...